Onderneming Anavex Life Sciences Corp.
Aandelen
AVXL
US0327973006
Biotechnologie & Medisch Onderzoek
Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
3,455 USD | +1,92% | -8,20% | -62,73% |
Vakgebied
Aantal werknemers: 40
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 58 | 05-07-13 | |
Sandra Boenisch
DFI | Director of Finance/CFO | 43 | 01-10-15 |
Edward Hammond
CTO | Chief Tech/Sci/R&D Officer | - | - |
Walter Kaufmann
CTO | Chief Tech/Sci/R&D Officer | - | 02-01-19 |
Stephan Toutain
COO | Chief Operating Officer | - | 05-03-18 |
David Goldberger
LAW | General Counsel | - | 06/11 |
Adebayo Laniyonu
PRN | Corporate Officer/Principal | - | 05-05-21 |
Daniel Klamer
PRN | Corporate Officer/Principal | - | 01-09-15 |
Juliana Daley
PRN | Corporate Officer/Principal | 37 | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 58 | 05-07-13 | |
Tom Skarpelos
FOU | Founder | 57 | 23-01-04 |
Jiong Ma
CHM | Chairman | 60 | 25-05-21 |
Steffen Thomas
BRD | Director/Board Member | 58 | 15-06-15 |
Peter Donhauser
BRD | Director/Board Member | 58 | 08-02-17 |
Director/Board Member | 51 | 02-03-18 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 82 112 511 | 79 530 715 ( 96,86 %) | 0 | 96,86 % |
Bedrijfsgegevens
Anavex Life Sciences Corp.
630 5th Avenue 20th floor
10111, New York
+844 689 3939
http://www.anavex.comSector
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-62,73% | 278 mln. | |
-1,79% | 103 mld. | |
+0,46% | 95,71 mld. | |
+1,69% | 22,02 mld. | |
-17,32% | 20,9 mld. | |
-9,30% | 17,85 mld. | |
-41,01% | 16,21 mld. | |
-14,94% | 15,52 mld. | |
+3,99% | 13,86 mld. | |
+36,33% | 12,04 mld. |
- Beurs
- Aandelen
- Koers AVXL
- Onderneming Anavex Life Sciences Corp.